Literature DB >> 10399007

Oral tolerance: mechanisms and therapeutic applications.

A M Faria1, H L Weiner.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10399007     DOI： 10.1016/s0065-2776(08)60787-7

Source DB:  PubMed          Journal:  Adv Immunol        ISSN： 0065-2776            Impact factor:   3.543


× No keyword cloud information.
  61 in total

1.  Induction of oral tolerance to the acetylcholine receptor for treatment of myasthenia gravis.

Authors:  H L Weiner
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  Oral tolerance, an active immunologic process mediated by multiple mechanisms.

Authors:  H L Weiner
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

Review 3.  CD40L in autoimmunity and mucosally induced tolerance.

Authors:  Mi-Na Kweon; Hiroshi Kiyono
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

4.  Mucosal CD8alpha+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties.

Authors:  Janine Bilsborough; Thaddeus C George; Anne Norment; Joanne L Viney
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

Review 5.  Immune modulating peptides for the treatment and suppression of multiple sclerosis.

Authors:  Ahmed H Badawi; Teruna J Siahaan
Journal:  Clin Immunol       Date:  2012-06-05       Impact factor: 3.969

6.  Innate profiles of cytokines implicated on oral tolerance correlate with low- or high-suppression of humoral response.

Authors:  Maria F Silva; Alice O Kamphorst; Elize A Hayashi; Maria Bellio; Claudia R Carvalho; Ana M C Faria; Kátia C C Sabino; Marsen G P Coelho; Alberto Nobrega; Daniel Tavares; Antonio C Silva
Journal:  Immunology       Date:  2010-03-16       Impact factor: 7.397

7.  Oral tolerance in the absence of naturally occurring Tregs.

Authors:  Daniel Mucida; Nino Kutchukhidze; Agustin Erazo; Momtchilo Russo; Juan J Lafaille; Maria A Curotto de Lafaille
Journal:  J Clin Invest       Date:  2005-06-02       Impact factor: 14.808

Review 8.  Allopeptides and the alloimmune response.

Authors:  Ankit Bharat; T Mohanakumar
Journal:  Cell Immunol       Date:  2007-07       Impact factor: 4.868

9.  Identification of the genes specifically expressed in orally tolerized T cells.

Authors:  Takayasu Gotoh; Wataru Ise; Atsuko Nonaka; Shuichi Hamaguchi; Satoshi Hachimura; Shuichi Kaminogawa
Journal:  Cytotechnology       Date:  2003-11       Impact factor: 2.058

10.  Transient blockade of CD40 ligand dissociates pathogenic from protective mucosal immunity.

Authors:  Arno Hänninen; Nathan R Martinez; Gayle M Davey; William R Heath; Leonard C Harrison
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.